Maland Medical (688273.SH) Focuses on Non-Invasive Brain-Computer Interface Technologies in Latest Prospectus Filing

Gelonghui September 8th丨Medlander(688273.SH) stated on the investor interaction platform,In the field of artificial intelligence, 1) Medlander Medical Technology Inc. continues to deepen the application of AI in the field of pelvic floor rehabilitation. Relying on clinical big data and large model technology, the company achieves intelligent in-depth analysis of evaluation data and provides highly personalized treatment plans for patients; 2) The company actively promotes the deep application of AI agents in enterprise-level scenarios, building an intelligent interaction system centered on large language models (LLM) and supported by vertical domain knowledge bases. It has launched a report interpretation agent and a pelvic floor health knowledge Q&A agent, providing professional medical report analysis and personalized home training program planning for patients with pelvic floor diseases; 3) Based on the technical accumulation of the PI-ONE system, the company deeply integrates multi-dimensional biological data with AI algorithms, constructing an intelligent beauty diagnosis and treatment platform covering the entire process of "detection-evaluation-plan-intervention," achieving intelligent decision support from quantitative analysis of skin conditions to personalized beauty solutions. In the field of brain-computer interfaces, the company focuses on non-invasive brain-computer interface directions and has already made progress in upper limb and hand movement.Robot, non-invasive neuromodulation, and multimodal physiological signal acquisition. The company is also actively promoting the research and development of a multimodal closed-loop neuromodulation system and an emotional interaction cognitive therapy system. Subsequent efforts will be made according to plan to advance the industrialization process of related products, with the aim of building a more complete brain-computer interface product matrix. Regarding ongoing projects: 1) The National Key R&D Program led by the company, "Research and Development of Multimodal Emotional Interactive Diagnostic and Treatment Equipment," is currently in the middle stage; 2) The joint research project of the Yangtze River Delta Science and Technology Innovation Community led by the company, "Key Technology Research on Limb Motor Function Rehabilitation Robot System Based on Motion Intention Perception," is currently in the early stage; 3) The Key R&D Program of Jiangsu Province led by the company, "Key Technology Research and Development of Multimodal Intelligent Hand Rehabilitation Robot Based on Central-Peripheral Closed-Loop Regulation," is currently in the clinical validation stage; 4) The Frontier Technology R&D Program of Jiangsu Province led by the subsidiary Ruishide, "Closed-Loop Neuromodulation Equipment and Key Technology R&D Based on Multimodal Brain Physiological Monitoring," has completed the project approval announcement.